CASPER Criteria for Psoriatic Arthritis

CASPAR criteria classify psoriatic arthritis by requiring inflammatory articular disease plus weighted clinical, laboratory, and radiographic psoriasis‑related features.

Current psoriasis, personal history of psoriasis, or family history of psoriasis
None0Personal history of psoriasis+1Family history of psoriasis: psoriasis in a first- or second-degree relative+1Current psoriasis: psoriatic skin or scalp disease present today, diagnosed by a rheumatologist or dermatologist+2
Typical psoriatic nail dystrophy
No0Yes+1
Rheumatic factor negative
No0Yes+1
Current dactylitis or history of dactylitis recorded by a rheumatologist
No0Yes+1
Juxtaarticular new bone formation on hand or foot x-ray
No0Yes+1

Indicazioni d'uso

Used to classify patients with suspected inflammatory articular disease when evaluating for psoriatic arthritis. Applied in individuals with joint, spine, or enthesitis symptoms to confirm PsA using ≥3 points from clinical, radiographic, and laboratory features. High sensitivity (≈88.7%) in early arthritis cohorts supports utility for standardized classification, research entry criteria, and strengthening diagnostic confidence alongside clinical assessment 1 [Level II evidence].

Approfondimenti e precauzioni

Identify PsA when inflammatory articular disease is present plus weighted features (psoriasis, nail changes, dactylitis, negative RF, juxta‑articular new bone). High sensitivity (88.7%) and specificity (≈90–100%) in early arthritis cohorts 1 [Level II evidence]. Misses some SAPHO or axial‑predominant disease 2 [Level III evidence]. Ultrasound‑confirmed enthesitis/tenosynovitis improves accuracy 3 [Level II evidence]. Use for classification—not as sole diagnostic rule.